PROGRAM ȘTIINȚIFIC

Friday, 16 February

13:30–13:50 Official opening
Conf. Dr. Viorica Rădoi, Dr. Mircea Dediu
Welcome message

13:50– 15:20 Session I – OncoGenetica (I)
Chair: Conf. Dr. Viorica Rădoi         

13:50– 14:10
Epigenetic regulation in cancer – the potential role of „epi-drugs” in oncology
Conf. Dr. Viorica Rădoi         

14:10– 14:30
Challenges in the interpretation of BRCA variants
Dr. Onda-Tabita Călugăru

14:30– 14:50
There is hereditary breast cancer beyond BRCA1 and BRCA2 – rare genetic syndromes of predisposition to breast cancer
Conf. Dr. Adrian Trifa, Dr. Iulia Perva, Dr. Iulia Simina, Dr. Cătălin Munteanu

14:50– 15:10
NIPT and maternal malignacy
Șef Lucrări. Dr. Lucian Pop

15:10– 15:20  Q&A

15:20– 16:00 Lunch Break

16:00– 16:30  Sattelite Symposium Eli – Lilly

16:30– 17:40  Session II –Surgery indications in patients with  high genetical risk
Chair: Prof. Dr. Alexandru Blidaru

16:30– 16:50 
Prophylactic contralateral  mastectomy in breast cancer patients
Dr. Aniela Nodiți, Prof. Dr. Alexandru Blidaru

16:50– 17:10 
Immediate breast reconstruction using alloplastic materials
Dr. Linda Cernodolea Kanaan, Prof. Dr. Alexandru Blidaru

17:10– 17:30 
Prophylactic gynecological procedures
Dr. Mihaela Alexandra Radu, Prof. Dr. Alexandru Blidaru

17:30– 17:40  Q&A

17:40– 18:10  Sattelite Symposium Roche

18:10– 18:30 Break

18:30– 20:00  Session III –Impact of predictive biomarkers in the treatment of solid tumors
Chair: Conf. Dr. Dana Stănculeanu

18:30– 18:50  
Precision medicine in the treatment of colangiocarcinoma
Dr. Răzvan Curcă

18:50– 19:10  
BRCA status assessment across various tumor locations: what for now and what for the future ?
Prof. Dr. Șerban Negru

19:10– 19:30  
Impact of predictive biomarkers in breast cancer
Conf. Dr. Dana Stănculeanu

19:30– 19:50 
EGFR pathway alterations in the management of colon and lung cancer
Prof. Dr. Tudor Ciuleanu

19:50– 20:00  Q&A

Saturday, 17 February

09:00– 10:30  Session IV – Personalized treatment choice in solid tumors (I)
Chair: Dr. Mircea Dediu

09:00– 09:20  Various options for  genomic testing in breast cancer : how to choose and how to use ?
Dr. Dragoș Median 

09.20– 09.40 How to refine the NSCLC treatment according to the PD-L1 expression !
Prof. Dr. Laura Mazilu

09.40– 10.00
Implementing biomarker assessment in the landscape of  urinary bladder approach
Conf. Dr. Laurentia Galeș

10.00– 10.20 Is gastric cancer moving towards a personalized treatment ?
Dr. Mircea Dediu

10.20– 10.30 Q&A

10.30– 10.45 Sattelite Symposium Servier Pharma

10:45– 11:00 Break

11:00– 11:15  Sattelite Symposium Merck
BAVENCIO: Extending survival for patients with advanced urothelial carcinoma
Dr. Mircea Dediu

11:15– 13:05 Session V – OncoGenetica (II)
Chair: Conf. Dr. Viorica Rădoi

11:15– 11:35
The role of a RCMG in the multidisciplinary and personalized approach to the oncological patient – results and perspectives within RCMG Dolj
Dr. Răzvan Pleșea

11:35– 11:55
Genetic factors involved in the etiopathology of skin cancers
Andra Dan, Conf. Dr. Viorica Rădoi

11:55– 12:15
The profile of genetic mutations in women diagnosed with gynecological cancers
Nicoleta Andreescu, Miruna Gug

12:15– 12:35
MiR – MiRacle diagnostic in oncology?
Dr. Iulian Hotinceanu

12:35– 12:55
Non-BRCA pathogenic variants identified in breast and ovarian cancer patients from Western Romania
Cristina GUG, Miruna GUG

12:55– 13:05  Q&A

13:05– 14:05 Sattelite Symposium AstraZeneca

14:05– 14:45 Lunch Break

14:45– 16:15 Session VI- Contribution of varius genomic and genetic detection in the   treatment of cancers
Moderator: Conf. Dr. Adina Croitoru

14:45– 15:05
Relevance of  MSI status in the treatment of digestive cancers
Conf. Dr. Adina Croitoru

15:05– 15:25
Confirmed and promising predictive biomarkers in ovarian and uterine cancers
Conf. Dr. Michael Schenker

15:25– 15:45
Updates in genetic testing of malignant melanoma
Asist. Univ. Dr. Cerasela Paraschiv

15:45– 16:05
Pathways to Progress: Unveiling the Latest Insights and Advancements in Lynch Syndrome Research from 2023 – a scientific review made by Romanian Society for Lynch Syndrome
Șef Lucrări Dr. Oana Voinea

16:05– 16:15  Q&A     

16:15– Official Closure
     

CONFERINȚA VA FI PRECEDATĂ DE WORKSHOP-UL

Noi orizonturi în oncogenetică – A hands on approach

16 februarie 2024

8.00-12.30

Locație: Spitalul Sanador

Workshop creditat cu 4 credite EMC

 PARTEA I – ASPECTE TEORETICE

1. Identificarea indivizilor eligibili pentru evaluarea riscului de cancer ereditar și consiliere genetică – Andra Dan

2. Componente ale evaluării genetice a riscului de cancere ereditare – Iulian Hotinceanu

3. Considerații privind testele genetice optime pentru fiecare caz în parte – Dr. Viorica Rădoi

4. Implicații etice, legale și sociale ale testării genetice în oncologie – Mălina Burtavel

PARTEA A II A – ASPECTE PRACTICE

1. Testare NGS și interpretare date de secvențiere

2. Examen citogenetic maduvă hematogenă

3. Mutații somatice și germline. Secvențiere și MLPA

4. Teste de farmacogenetică – Gene acționabile în patologia malignă

5. Principii de elaborare a planului de management în funcție de genotipul tumoral și al pacientului

Taxă de participare la workshop

Taxa unică: 150 RON